Your browser doesn't support javascript.
loading
A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy.
Büttner, Florian A; Winter, Stefan; Stühler, Viktoria; Rausch, Steffen; Hennenlotter, Jörg; Füssel, Susanne; Zastrow, Stefan; Meinhardt, Matthias; Toma, Marieta; Jerónimo, Carmen; Henrique, Rui; Miranda-Gonçalves, Vera; Kröger, Nils; Ribback, Silvia; Hartmann, Arndt; Agaimy, Abbas; Stöhr, Christine; Polifka, Iris; Fend, Falko; Scharpf, Marcus; Comperat, Eva; Wasinger, Gabriel; Moch, Holger; Stenzl, Arnulf; Gerlinger, Marco; Bedke, Jens; Schwab, Matthias; Schaeffeler, Elke.
Afiliação
  • Büttner FA; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Auerbachstrasse 112, 70376, Stuttgart, Germany.
  • Winter S; University of Tuebingen, Tuebingen, Germany.
  • Stühler V; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Auerbachstrasse 112, 70376, Stuttgart, Germany.
  • Rausch S; University of Tuebingen, Tuebingen, Germany.
  • Hennenlotter J; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany.
  • Füssel S; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany.
  • Zastrow S; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany.
  • Meinhardt M; Department of Urology, University Hospital and Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
  • Toma M; Department of Urology, University Hospital and Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
  • Jerónimo C; Institute of Pathology, University Hospital and Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
  • Henrique R; Institute of Pathology, University Hospital and Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
  • Miranda-Gonçalves V; Current address: Institute of Pathology, University of Bonn, Bonn, Germany.
  • Kröger N; Cancer Biology & Epigenetics Group-Research Center, Portuguese Oncology Institute of Porto (CI-IPOP, IPO Porto), Porto, Portugal.
  • Ribback S; Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar-University of Porto (ICBAS-UP), Porto, Portugal.
  • Hartmann A; Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal.
  • Agaimy A; Cancer Biology & Epigenetics Group-Research Center, Portuguese Oncology Institute of Porto (CI-IPOP, IPO Porto), Porto, Portugal.
  • Stöhr C; Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar-University of Porto (ICBAS-UP), Porto, Portugal.
  • Polifka I; Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal.
  • Fend F; Cancer Biology & Epigenetics Group-Research Center, Portuguese Oncology Institute of Porto (CI-IPOP, IPO Porto), Porto, Portugal.
  • Scharpf M; Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar-University of Porto (ICBAS-UP), Porto, Portugal.
  • Comperat E; Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal.
  • Wasinger G; Department of Urology, University of Greifswald, Greifswald, Germany.
  • Moch H; Institute of Pathology, University Medicine Greifswald, Greifswald, Germany.
  • Stenzl A; Institute of Pathology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), University Hospital, Erlangen, Germany.
  • Gerlinger M; Institute of Pathology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), University Hospital, Erlangen, Germany.
  • Bedke J; Institute of Pathology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), University Hospital, Erlangen, Germany.
  • Schwab M; Institute of Pathology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), University Hospital, Erlangen, Germany.
  • Schaeffeler E; Institute of Pathology and Neuropathology, University Hospital Tuebingen, Tuebingen, Germany.
Genome Med ; 14(1): 105, 2022 09 15.
Article em En | MEDLINE | ID: mdl-36109798
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Idioma: En Ano de publicação: 2022 Tipo de documento: Article